Melissa Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Melissa Johnson has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Amar Rangan
Hull York Medical School & Department of Health Sciences University of York Heslington, York YO10 5DD United Kingdom
5 shared publications - Katherine Swainston
School of Psychology, Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle NE2 4HH, UK
5 shared publications - Lucksy Kottam
South Tees Hospitals NHS Foundation Trust
5 shared publications - Natalie Louise Clark
South Tees Hospitals NHS Foundation Trust, United Kingdom
5 shared publications Amar Rangan
York Trials Unit, Department of Health Sciences York England University of York Department of Health Sciences
2 shared publicationsAda Keding
York Trials Unit, Department of Health Sciences York England University of York Department of Health Sciences
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 6, 105
Delivery of Physiotherapy and effect on patient outcomes: A secondary data analysis of the Early Structured Physiotherapy programme of the UK FROST Trial
Background Frozen shoulder can cause significant pain, restricted movement, and functional impairment. It affects up to 10% of the population and occurs five times more frequently in diabetics. Evidence from the United Kingdom Frozen Shoulder Trial (UK FROST) suggests no single intervention is clinically superior. Methods To investigate the relationship between the delivery of physiotherapy and its effect on patient outcomes for adult patients with a frozen shoulder , a secondary analysis of the Early Structured Physiotherapy (ESP) programme of the UK FROST trial was completed. The study took place at thirty National Health Service (NHS) hospitals in the United Kingdom (UK). Participants were adults (≥18 years) with unilateral frozen shoulder, characterised by restriction of passive external rotation (≥50%) in the affected shoulder. ESP was a bespoke intervention designed for UK FROST. At the earliest opportunity, an intra-articular steroid injection was administered. The primary outcome was the Oxford Shoulder Score (OSS), a 12-item patient-reported outcome measure of shoulder pain and function with five response categories and an overall scale ranging from 0 (worst) to 48 (best). A Numeric Rating Scale for pain in the past 24 hours was also collected. Results There was no significant linear association between the number of ESP sessions attended and OSS at 12 months (Pearson’s r = 0.018, p = 0.87, n = 88) nor at three or six months. To determine if there was an optimal number of ESP sessions, a ROC curve analysis indicated poor discrimination power with Area Under the Curve (AUC) values at three (AUC = 0.5953), six (AUC = 0.5414) and 12 months (AUC = 0.5935). Conclusions There does not appear to be an optimal target number of sessions, and instead treatment plans should be tailored to the personal care of patients in shared decision-making with the physiotherapist. Clinical Trial Registration number. ISRCTN48804508. Contributions of Paper • This paper evaluates a bespoke and novel intervention, early structured physiotherapy, within the UK FROST Trial. • This paper provides some context into key predictors (diabetes and baseline Oxford Shoulder Score) of patient outcomes within this trial population and demonstrates no relationship, or discriminatory power, between number of physiotherapy sessions and patient outcome. • The evidence advocates for more flexible personalised patient care in conjunction with shared decision-making with the physiotherapist over standardised care pathways with a prescriptive number of sessions required.
- 22 July 2026
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 6, 105
Open AccessDelivery of Physiotherapy and effect on patient outcomes: A secondary data analysis of the Early Structured Physiotherapy programme of the UK FROST Trial
Background Frozen shoulder can cause significant pain, restricted movement, and functional impairment. It affects up to 10% of the population and occurs five times more frequently in diabetics. Evidence from the United Kingdom Frozen Shoulder Trial (UK FROST) suggests no single intervention is clinically superior. Methods To investigate the relationship between the delivery of physiotherapy and its effect on patient outcomes for adult patients with a frozen shoulder , a secondary analysis of the Early Structured Physiotherapy (ESP) programme of the UK FROST trial was completed. The study took place at thirty National Health Service (NHS) hospitals in the United Kingdom (UK). Participants were adults (≥18 years) with unilateral frozen shoulder, characterised by restriction of passive external rotation (≥50%) in the affected shoulder. ESP was a bespoke intervention designed for UK FROST. At the earliest opportunity, an intra-articular steroid injection was administered. The primary outcome was the Oxford Shoulder Score (OSS), a 12-item patient-reported outcome measure of shoulder pain and function with five response categories and an overall scale ranging from 0 (worst) to 48 (best). A Numeric Rating Scale for pain in the past 24 hours was also collected. Results There was no significant linear association between the number of ESP sessions attended and OSS at 12 months (Pearson’s r = 0.018, p = 0.87, n = 88) nor at three or six months. To determine if there was an optimal number of ESP sessions, a ROC curve analysis indicated poor discrimination power with Area Under the Curve (AUC) values at three (AUC = 0.5953), six (AUC = 0.5414) and 12 months (AUC = 0.5935). Conclusions There does not appear to be an optimal target number of sessions, and instead treatment plans should be tailored to the personal care of patients in shared decision-making with the physiotherapist. Clinical Trial Registration number. ISRCTN48804508. Contributions of Paper • This paper evaluates a bespoke and novel intervention, early structured physiotherapy, within the UK FROST Trial. • This paper provides some context into key predictors (diabetes and baseline Oxford Shoulder Score) of patient outcomes within this trial population and demonstrates no relationship, or discriminatory power, between number of physiotherapy sessions and patient outcome. • The evidence advocates for more flexible personalised patient care in conjunction with shared decision-making with the physiotherapist over standardised care pathways with a prescriptive number of sessions required.
- Open Access
- 9 October 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (12) , 3951-3961
Defining a core outcome set for hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome: A Delphi consensus study
The reported prevalence of hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) is unclear due to complex presentations and lack of awareness amongst professionals, contributing to diagnostic and management uncertainties. Standardising an outcome measure to assess symptoms most important to patients should help determine the impact of interventions. This Delphi study aims to reach a consensus with stakeholders on the core outcome set for children and adults with HSD/hEDS. A three-round modified Delphi consensus study with a follow-up consensus meeting was used. Stakeholder groups consisted of (1) individuals with HSD/hEDS; (2) family/friends/carers and (3) healthcare professionals. Participants could belong to more than one stakeholder group. They rated 74 symptoms using a 9-point Likert scale: 1 “not important to 9 “critically important”. Symptoms achieving a consensus rating of ≥ 70.0% critical importance across all groups were included. In Round 1, 766 responses were received from 600 participants, reducing to 566 responses from 438 participants by Round 3, with 53 participating in the consensus meeting. Overall, 30 symptoms met the ≥ 70.0% critically important threshold to be included in the final core outcome set. These were categorised under the specialties of musculoskeletal and orthopaedics, social, pain, gynaecology and urology, negative affect, neurological, gastrointestinal and “other”. This study is the first to identify by consensus the core outcome set to be measured for patients with HSD/hEDS. The importance of these outcomes was confirmed by individuals living with the condition, their family, friends, carers and relevant healthcare professionals. Trial registration: IRAS ID: 326,855; East Midlands — Leicester South REC (reference: 23/EM/0143); Protocol registered with the COMET Initiative. Key Points• There is a lack of standardised outcome measure for HSD/hEDS research studies due to the heterogeneity of symptom presentations.• Symptoms across musculoskeletal and orthopaedics, social, pain, gynaecology and urology, negative affect, neurological, gastrointestinal and “other” specialties were identified as the core outcome set defined as ≥ 70.0% critically important to measure for individuals with HSD/hEDS.• There were a significant number of symptoms, widely recognised in the literature to be comorbid to HSD/hEDS, that reached a critical importance threshold of 50.0–69.9%, restricting the core outcome set to only those that met 70% or above may be limiting.
- 9 October 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (12) , 3951-3961
Open AccessDefining a core outcome set for hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome: A Delphi consensus study
The reported prevalence of hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) is unclear due to complex presentations and lack of awareness amongst professionals, contributing to diagnostic and management uncertainties. Standardising an outcome measure to assess symptoms most important to patients should help determine the impact of interventions. This Delphi study aims to reach a consensus with stakeholders on the core outcome set for children and adults with HSD/hEDS. A three-round modified Delphi consensus study with a follow-up consensus meeting was used. Stakeholder groups consisted of (1) individuals with HSD/hEDS; (2) family/friends/carers and (3) healthcare professionals. Participants could belong to more than one stakeholder group. They rated 74 symptoms using a 9-point Likert scale: 1 “not important to 9 “critically important”. Symptoms achieving a consensus rating of ≥ 70.0% critical importance across all groups were included. In Round 1, 766 responses were received from 600 participants, reducing to 566 responses from 438 participants by Round 3, with 53 participating in the consensus meeting. Overall, 30 symptoms met the ≥ 70.0% critically important threshold to be included in the final core outcome set. These were categorised under the specialties of musculoskeletal and orthopaedics, social, pain, gynaecology and urology, negative affect, neurological, gastrointestinal and “other”. This study is the first to identify by consensus the core outcome set to be measured for patients with HSD/hEDS. The importance of these outcomes was confirmed by individuals living with the condition, their family, friends, carers and relevant healthcare professionals. Trial registration: IRAS ID: 326,855; East Midlands — Leicester South REC (reference: 23/EM/0143); Protocol registered with the COMET Initiative. Key Points• There is a lack of standardised outcome measure for HSD/hEDS research studies due to the heterogeneity of symptom presentations.• Symptoms across musculoskeletal and orthopaedics, social, pain, gynaecology and urology, negative affect, neurological, gastrointestinal and “other” specialties were identified as the core outcome set defined as ≥ 70.0% critically important to measure for individuals with HSD/hEDS.• There were a significant number of symptoms, widely recognised in the literature to be comorbid to HSD/hEDS, that reached a critical importance threshold of 50.0–69.9%, restricting the core outcome set to only those that met 70% or above may be limiting.
- Open Access
- 12 January 2024
- Published by Springer Nature in Systematic Reviews
- Vol. 13 (1) , 1-6
Exploring the biopsychosocial impact of hypermobility spectrum disorders and Ehlers-Danlos syndrome in an adult population: a protocol for a scoping review
Background: Conditions such as hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndrome (EDS) are most often diagnosed when an individual has joint flexibility beyond the normal physiological limits. Additional characteristics and symptoms include pain and fatigue with individuals also being more likely to report feelings of anxiety and depression. Due to the varied presentation of these conditions, there is a lack of understanding amongst the various healthcare professionals (HCPs) individuals present to, leading to delayed diagnoses and negative experiences for the individuals themselves. This scoping review therefore aims to map the known biopsychosocial impact of adults with HSD and EDS. Methods: The scoping review will follow the six-step framework as outlined by Arskey and O’Malley and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) checklist. The search will be conducted using the following databases: AMED, CINAHL, Cochrane Library, Embase, MEDLINE, PsycINFO, PubMed PEDro. Full-text published articles in the English language (excluding literature and systematic reviews) with adult samples (over the age of 18 years) and a diagnosis of a HSD or EDS, published between 2012 and 2022, will be included in the review. Discussion: This review will aim to explore the existing literature for the reported biopsychosocial impact of adults with a HSD or EDS. It will also aim to further acknowledge the gaps in understanding of the condition, how the condition and the impact of the condition is being measured and what HCPs are involved in supporting such individuals. These gaps will be used to inform a future systematic review. It is the overall goal to increase the knowledge of HCPs and the quality of life of adults living with a joint hypermobility condition.
- 12 January 2024
- Published by Springer Nature in Systematic Reviews
- Vol. 13 (1) , 1-6
Open AccessExploring the biopsychosocial impact of hypermobility spectrum disorders and Ehlers-Danlos syndrome in an adult population: a protocol for a scoping review
Background: Conditions such as hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndrome (EDS) are most often diagnosed when an individual has joint flexibility beyond the normal physiological limits. Additional characteristics and symptoms include pain and fatigue with individuals also being more likely to report feelings of anxiety and depression. Due to the varied presentation of these conditions, there is a lack of understanding amongst the various healthcare professionals (HCPs) individuals present to, leading to delayed diagnoses and negative experiences for the individuals themselves. This scoping review therefore aims to map the known biopsychosocial impact of adults with HSD and EDS. Methods: The scoping review will follow the six-step framework as outlined by Arskey and O’Malley and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) checklist. The search will be conducted using the following databases: AMED, CINAHL, Cochrane Library, Embase, MEDLINE, PsycINFO, PubMed PEDro. Full-text published articles in the English language (excluding literature and systematic reviews) with adult samples (over the age of 18 years) and a diagnosis of a HSD or EDS, published between 2012 and 2022, will be included in the review. Discussion: This review will aim to explore the existing literature for the reported biopsychosocial impact of adults with a HSD or EDS. It will also aim to further acknowledge the gaps in understanding of the condition, how the condition and the impact of the condition is being measured and what HCPs are involved in supporting such individuals. These gaps will be used to inform a future systematic review. It is the overall goal to increase the knowledge of HCPs and the quality of life of adults living with a joint hypermobility condition.
- Open Access
- 13 December 2023
- Published by Springer Nature in Rheumatology International
- Vol. 44 (1) , 41-55
Psychological interventions to improve pain, fatigue, anxiety, depression, and quality of life in children and adults with hypermobility spectrum disorders and Ehlers-Danlos syndrome: a systematic review
Hypermobility spectrum disorders (HSD) affect individuals across physical, psychological and social domains, making assessment and management difficult. Management for this condition primarily focuses on addressing the musculoskeletal complaints using physiotherapy rather than the additional manifestations such as fatigue, anxiety and depression. This systematic review aims to identify psychological interventions and assess whether they improve the lived experiences of individuals with HSD. It also aims to assess which psychological interventions were most effective, which symptoms were most effectively managed by a psychological intervention, and whether there were differences between children and adults. Studies were included if they were a randomised controlled trial or pre/post-test design, a sample of any age and clinical diagnosis of HSD (including Ehlers-Danlos syndrome), used a psychological intervention and assessed the effect of the intervention on lived experiences using appropriate outcome measures. Risk of bias was assessed using the Mixed Methods Appraisal Tool. The results were narratively synthesised. Six studies were included in the review, one isolated psychological intervention and five incorporated a psychological intervention within a multidisciplinary programme. The interventions predominantly aimed to reduce pain including intensity, interference, pain-related fear and catastrophising, with anxiety and depression, affect, daily living, fatigue also being evaluated. The most beneficial psychological interventions were those delivered alongside physiotherapy in an outpatient or community setting, improving both the physical and psychological aspects of pain, subsequently improving quality of life. However, there lacks randomised controlled trials with larger samples to definitively confirm the significant findings discussed in this review.
- 13 December 2023
- Published by Springer Nature in Rheumatology International
- Vol. 44 (1) , 41-55
Open AccessPsychological interventions to improve pain, fatigue, anxiety, depression, and quality of life in children and adults with hypermobility spectrum disorders and Ehlers-Danlos syndrome: a systematic review
Hypermobility spectrum disorders (HSD) affect individuals across physical, psychological and social domains, making assessment and management difficult. Management for this condition primarily focuses on addressing the musculoskeletal complaints using physiotherapy rather than the additional manifestations such as fatigue, anxiety and depression. This systematic review aims to identify psychological interventions and assess whether they improve the lived experiences of individuals with HSD. It also aims to assess which psychological interventions were most effective, which symptoms were most effectively managed by a psychological intervention, and whether there were differences between children and adults. Studies were included if they were a randomised controlled trial or pre/post-test design, a sample of any age and clinical diagnosis of HSD (including Ehlers-Danlos syndrome), used a psychological intervention and assessed the effect of the intervention on lived experiences using appropriate outcome measures. Risk of bias was assessed using the Mixed Methods Appraisal Tool. The results were narratively synthesised. Six studies were included in the review, one isolated psychological intervention and five incorporated a psychological intervention within a multidisciplinary programme. The interventions predominantly aimed to reduce pain including intensity, interference, pain-related fear and catastrophising, with anxiety and depression, affect, daily living, fatigue also being evaluated. The most beneficial psychological interventions were those delivered alongside physiotherapy in an outpatient or community setting, improving both the physical and psychological aspects of pain, subsequently improving quality of life. However, there lacks randomised controlled trials with larger samples to definitively confirm the significant findings discussed in this review.
- Open Access
- 10 March 2023
- Published by Springer Nature in Rheumatology International
- Vol. 43 (6) , 985-1014
The biopsychosocial impact of hypermobility spectrum disorders in adults: a scoping review
Joint hypermobility affects approximately 30% of the United Kingdom (UK) population, characterised by the ability to move joints beyond the physiological limits. Associated conditions include Ehlers-Danlos syndrome and hypermobility spectrum disorders, affecting individuals across physical, psychological and social levels detrimentally impacting their health and wellbeing. The scoping review aims to describe the known biopsychosocial impact of joint hypermobility conditions in adults over the last decade. Additional objectives include to (1) identify the types of studies that address these factors, (2) to understand how the impact of the condition is measured and managed and (3) what healthcare professionals (HCPs) are involved. The scoping review was conducted using the five-stage framework by Arksey and O’Malley. The search strategy related to two main keywords, “hypermobility” and, “biopsychosocial” across a number of electronic databases. A pilot search was conducted to determine the suitability of the databases and terms. Following the search, the data was extracted and charted, summarised and narratively reported. 32 studies met the inclusion criteria. The majority were conducted in either the UK or United States of America and case–control in design. The biopsychosocial impact was wide-ranging including, but not limited to, musculoskeletal system and dermatology, gastroenterology, mood and anxiety disorders, education and employments. This review is the first of its kind to summarise all reported symptoms and impact of joint hypermobility conditions in adults, highlighting a clear need to promote a multidisciplinary and holistic approach in raising awareness of these conditions and improving their management.
- 10 March 2023
- Published by Springer Nature in Rheumatology International
- Vol. 43 (6) , 985-1014
Open AccessThe biopsychosocial impact of hypermobility spectrum disorders in adults: a scoping review
Joint hypermobility affects approximately 30% of the United Kingdom (UK) population, characterised by the ability to move joints beyond the physiological limits. Associated conditions include Ehlers-Danlos syndrome and hypermobility spectrum disorders, affecting individuals across physical, psychological and social levels detrimentally impacting their health and wellbeing. The scoping review aims to describe the known biopsychosocial impact of joint hypermobility conditions in adults over the last decade. Additional objectives include to (1) identify the types of studies that address these factors, (2) to understand how the impact of the condition is measured and managed and (3) what healthcare professionals (HCPs) are involved. The scoping review was conducted using the five-stage framework by Arksey and O’Malley. The search strategy related to two main keywords, “hypermobility” and, “biopsychosocial” across a number of electronic databases. A pilot search was conducted to determine the suitability of the databases and terms. Following the search, the data was extracted and charted, summarised and narratively reported. 32 studies met the inclusion criteria. The majority were conducted in either the UK or United States of America and case–control in design. The biopsychosocial impact was wide-ranging including, but not limited to, musculoskeletal system and dermatology, gastroenterology, mood and anxiety disorders, education and employments. This review is the first of its kind to summarise all reported symptoms and impact of joint hypermobility conditions in adults, highlighting a clear need to promote a multidisciplinary and holistic approach in raising awareness of these conditions and improving their management.
- 3 April 2021
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 17, 254-260
Tendon transfers for irreparable rotator cuff tears
- 3 April 2021
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 17, 254-260
Tendon transfers for irreparable rotator cuff tears